Xiaflex, known scientifically as collagenase clostridium histolyticum, is a biologic medication derived from the enzymatic proteins produced by the bacterium Clostridium histolyticum. This unique composition allows Xiaflex to target and break down specific types of collagen found in fibrous tissue, making it particularly effective for certain musculoskeletal conditions. The FDA has granted approval for Xiaflex…
1. Introduction to Sitagliptin Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, marketed under the brand name Januvia® (and as Janumet® in combination with metformin). It is a cornerstone therapy in the management of type 2 diabetes mellitus (T2DM). As a prescription-only medication, it requires careful consideration by pharmacists to ensure safe and effective use. 2….
Sulfasalazine, commonly known by its brand name Azulfidine, is a multifaceted medication primarily classified as a disease-modifying antirheumatic drug (DMARD). It is widely utilized in the management of various rheumatic conditions, including rheumatoid arthritis (RA) and several forms of inflammatory bowel disease (IBD) such as ulcerative colitis and Crohn’s disease. As a sulfa medication, it…
1. Introduction and Indications Tysabri (natalizumab) is a humanized monoclonal antibody approved by the FDA for the treatment of relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS. It is also indicated for adults with moderate-to-severe Crohn’s disease who have not responded adequately to conventional therapies or…
1. Introduction Lamivudine (3′-hydroxy-3′-thiacidopyrimidine, 3TC) is a nucleoside reverse transcriptase inhibitor (NRTI) and one of the most widely used antiviral agents in the management of HIV infection and chronic hepatitis B virus (HBV) disease. Its broad-spectrum activity against both HIV-1 and HIV-2, as well as HBV, makes it an essential component of combination antiretroviral therapy…
1. Overview and Indications Dimethyl fumarate (DMF), marketed under the brand name Tecfidera, is an FDA-approved disease-modifying therapy (DMT) for adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS). Its use is supported by robust clinical evidence demonstrating efficacy in reducing relapse…
1. Introduction Irinotecan is a topoisomerase I inhibitor widely used in the management of various gastrointestinal malignancies. It is a prodrug metabolized to its active form, SN-38, which exerts cytotoxic effects primarily during the S and G2 phases of the cell cycle by stabilizing DNA-topoisomerase I cleavable complexes, leading to DNA strand breaks and apoptosis….
1. Introduction & Classification Femara (generic name: Letrozole) is a prescription medication classified as an Aromatase Inhibitor (AI), specifically a nonsteroidal, competitive inhibitor of the aromatase enzyme. It is widely used in oncology for the treatment and prevention of hormone receptor-positive breast cancer in postmenopausal women. 2. Mechanism of Action Letrozole exerts its anticancer effect…
1. Introduction and Classification Nabumetone is a member of the nonsteroidal anti-inflammatory drugs (NSAID) class, but unlike many of its counterparts, it is not a corticosteroid or classic NSAID such as ibuprofen or diclofenac. Instead, it is classified as a prodrug—a biologically inactive compound that undergoes hepatic metabolism to produce the active metabolite, 6-methoxy-2-naphthyl acetic…
1. Introduction Arava is a synthetic oral disease-modifying antirheumatic drug (DMARD) primarily indicated for the management of moderate to severe rheumatoid arthritis (RA). It is also used off-label in other inflammatory arthritides such as psoriatic arthritis and certain forms of vasculitis. Its mechanism, safety profile, and complex pharmacokinetics require careful consideration by healthcare professionals. 2. Mechanism of…
1. Introduction Sunitinib mesylate (Sutent®) is a multikinase inhibitor approved by the FDA and EMA for several advanced malignancies. It is classified as a targeted therapy, specifically a tyrosine kinase inhibitor (TKI), with broad activity against receptor tyrosine kinases (RTKs) implicated in tumor growth, angiogenesis, and metastasis. Its use requires careful clinical oversight due to…
1. Drug Classification & Indications Dupixent (dupilumab) is a monoclonal antibody that selectively inhibits the interleukin-4 receptor alpha (IL-4Rα), thereby blocking signaling of both IL-4 and IL-13, two key cytokines implicated in type 2 inflammation. Indications: 2. Mechanism of Action 3. Dosing & Administration Adults and Children: Special Considerations: 4. Pharmacovigilance & Safety Monitoring Common…
1. Drug Classification & Mechanism of Action Alprazolam is a short-acting benzodiazepine, widely prescribed for the management of anxiety disorders and panic disorder. Benzodiazepines, including alprazolam, act as positive allosteric modulators at the GABA-A receptor complex, enhancing the inhibitory effects of gamma-aminobutyric acid (GABA), leading to anxiolytic, sedative, muscle relaxant, and anticonvulsant properties. 2. Indications…
1. Overview and Chemical Profile Cyclopentolate hydrochloride ophthalmic solution (CPH) is a topical mydriatic and cycloplegic agent widely used in ophthalmology to induce pupil dilation (mydriasis) and paralysis of the ciliary muscle (cycloplegia). Its active ingredient, cyclopentolate hydrochloride, is a tertiary amine with anticholinergic properties. The solution contains 0.5%, 1%, or 2% cyclopentolate hydrochloride as…
What is ZERBAXA? ZERBAXA is a prescription antibiotic medication composed of two active ingredients: Together, ceftolozane and tazobactam provide a powerful treatment option against complicated infections caused by resistant bacteria. Uses of ZERBAXA ZERBAXA is FDA-approved for the treatment of adults (18 years and older) with: Clinicians may also use ZERBAXA off-label for other infections…
Notifications
